prophylactic anticoagulation – Page 2 – Communicable Diseases Research

Utility of d-dimer for diagnosis of deep vein thrombosis in coronavirus disease-19 infection

코로나바이러스 질병-19 감염에서 심부정맥 혈전증 진단을 위한 d-dimer의 유용성

Article

Published on 2021-01-012022-09-11
Journal: Journal of vascular surgery. Venous and lymphatic [Category] 바이오마커,

[키워드] 95% confidence interval age Analysis anticoagulation both groups Chain Reaction Cohort consecutive patient consecutive patients coronavirus coronavirus disease Coronavirus disease-19 COVID-19 criteria Cutoff D-dimer D-dimer levels Deep vein Deep vein thrombosis defined determine diabetes Diagnosis dimer DVT elevated Ethnicity Factor group groups Hemodialysis heparin in both group Infection interquartile range less median multivariable analyses multivariable analysis Negative predictive value no difference no differences Odds ratio Patient patients with COVID-19 polymerase chain polymerase chain reaction predict Predictive Predictive value Prophylactic prophylactic anticoagulation Prophylaxis selected sensitivity Sex specificity statistically significant thrombosis two groups venous was determined well Wells DVT criteria. with COVID-19
[DOI] 10.1016/j.jvsv.2020.07.009 PMC 바로가기 [Article Type] Article

Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies

COVID-19 중증 환자에서 중간 용량 대 표준 용량 예방적 항응고제 및 스타틴 요법 대 위약: INSPIRATION/INSPIRATION-S 연구의 이론적 근거 및 설계

Article

Published on 2020-12-012022-09-11
Journal: Thrombosis research [Category] 임상,

[키워드] all-cause mortality Analysis anticoagulation antithrombotic therapy Arterial thrombosis atorvastatin bleeding Chain Reaction cohorts Composite Controlled trial coronavirus disease Coronavirus disease 2019 COVID-19 death double-blind eligibility criteria Enrollment Exploratory analyses Exploratory analysis extracorporeal membrane oxygenation factorial design hallmark hallmarks help hypothese Hypothesis immune response include independent inferiority inspiration intensity intention-to-treat intermediate limit liver enzyme liver enzymes major bleeding management manifestation matching placebo modified intention-to-treat Myopathy non-inferiority non-inferiority margin normal limit Odds ratio open open label Patient patients with COVID-19 per-protocol performed Placebo Platelet Platelet count polymerase chain polymerase chain reaction Prevent primary endpoint Prophylactic prophylactic anticoagulation question randomization Randomized Randomized controlled trial rationale Result reverse transcription reverse transcription polymerase chain reaction safety endpoint screened secondary endpoint Standard dose Standard-dose statin Stratified randomization subgroup tested therapy thrombocytopenia thrombosis thrombotic event Thrombotic events undergo Venous Thromboembolism Ventilator-free days VTE
[DOI] 10.1016/j.thromres.2020.09.027 PMC 바로가기 [Article Type] Article

[Association of D-dimer, inflammatory markers, cytokines abnormality, and disease severity in COVID-19 severe/critical patients in Wuhan]

[우한 코로나19 중증/중증환자의 D-dimer, 염증 표지자, 사이토카인 이상 및 질병 중증도의 연관성]

Article

Published on 2020-11-142022-09-11
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zaz [Category] SARS, 바이오마커,

[키워드] abnormality age Analysis analyzed ANC anticoagulant therapy association cardiovascular disease Cerebrovascular disease changes in Chi-square chi-square test Chinese Chronic diseases Coagulation collected COVID-19 COVID-19 infection Critical cytokine Cytokines D-dimer D-dimer levels disease severity dysfunction Dyspnea English fatigue help hsCRP hypertension IL-6 IL-8 immune dysfunction IMPROVE Inflammatory indicators inflammatory markers Mann-Whitney U test medical record medical records men Patient patient age patients PCT performed Prevalence Prophylactic prophylactic anticoagulation proportion single center statistical analyses Student t test Symptom T Test the median the patient TNF-α treated Treatment WBC were assessed women Wuhan
[DOI] 10.3760/cma.j.issn.0253-2727.2020.11.008 PMC 바로가기 [Article Type] Article

Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review

COVID-19 관련 혈전증 환자에 대한 접근: 사례 기반 검토

Review

Published on 2020-10-012022-09-11
Journal: The oncologist [Category] SARS, 바이오마커,

[키워드] anticoagulation approach caused characterized Clinical practice coagulation test Coagulopathy coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19-associated coagulopathy current D-dimer levels diagnostic distill elevated Evidence global pandemic hospitalized patient hyperfibrinogenemia implication information management management guideline management guidelines Mild Novel coronavirus novel coronavirus SARS-CoV-2 Patient patients with COVID-19 populations Prophylactic prophylactic anticoagulation prophylactic doses prothrombin Prothrombin time Randomized controlled trial receive reported respiratory Respiratory illness Retrospective study review SARS-CoV-2 severe respiratory illness Standard dose Support Surveillance thrombocytopenia Thromboembolism thrombosis Variation variations
[DOI] 10.1634/theoncologist.2020-0682 PMC 바로가기 [Article Type] Review